Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis

BackgroundHER-2 (c-erbB2/Neu) predicts the prognosis of and may influence treatment responses in breast cancer. HER-2 activity induces the cytoplasmic location of p21WAFI/CIPI in cell culture, accompanied by resistance to apoptosis. p21WAFI/CIPI is a cyclin-dependent kinase inhibitor activated by p53 to produce cell cycle arrest in association with nuclear localisation of p21WAFI/CIPI . We previously showed that higher levels of cytoplasmic p21WAFI/CIPI in breast cancers predicted reduced survival at 5 years. The present study examined HER-2 and p21WAFI/CIPI expression in a series of breast cancers with up to 9 years of follow-up, to evaluate whether in vitro findings were related to clinical data and the effect on outcome.MethodsThe CB11 anti-HER2 monoclonal antibody and the DAKO Envision Plus system were used to evaluate HER-2 expression in 73 patients. p21WAFI/CIPI staining was performed as described previously using the mouse monoclonal antibody Ab-1 (Calbiochem, Cambridge, MA, USA).ResultsHER-2 was evaluable in 67 patients and was expressed in 19% of cases, predicting reduced overall survival (P = 0.02) and reduced relapse-free survival (P = 0.004; Cox regression model). HER-2-positive tumours showed proportionately higher cytoplasmic p21WAFI/CIPI staining using an intensity distribution score (median, 95) compared with HER-2-negative cancers (median, 47) (P = 0.005). There was a much weaker association between nuclear p21WAFI/CIPI and HER-2 expression (P = 0.05), suggesting an inverse relationship between nuclear p21WAF1/CIP1 and HER-2.ConclusionThis study highlights a new pathway by which HER-2 may modify cancer behaviour. HER-2 as a predictor of poor prognosis may partly relate to its ability to influence the relocalisation of p21WAFI/CIPI from the nucleus to the cytoplasm, resulting in a loss of p21WAFI/CIPI tumour suppressor functions. Cytoplasmic p21WAFI/CIPI may be a surrogate marker of functional HER-2 in vivo.

• Publication year

  2003

• Venue

  Breast Cancer Research

• Publication date

  2003-10-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/bcr654PMID 14580260PMCID 314414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Problems in Breast Pathology

  2006cited by this paper
• The Nottingham prognostic index in primary breast cancer

  2005cited by this paper
• The Cyclin-dependent Kinase Inhibitor p21CIP/WAF Is a Positive Regulator of Insulin-like Growth Factor I-induced Cell Proliferation in MCF-7 Human Breast Cancer Cells*

  2003cited by this paper
• Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres

  2003cited by this paper
• p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis

  2003influential reference
• The cyclin dependent kinase inhibitor p21 CIP/WAF is a positive regulator of IGF-1-induced Cell proliferation in MCF-7 human breast cancer cells

  2003cited by this paper
• Expert Commentary.

  2002cited by this paper
• Anti‐human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer

  2002cited by this paper
• Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries.

  2002cited by this paper
• HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

  2001cited by this paper
• Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer.

  2001cited by this paper
• p 21 waf correlates with DNA replication but not with prognosis in invasive breast cancer

  2001cited by this paper
• p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer.

  2001cited by this paper
• Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis.

  2001cited by this paper
• Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.

  2001cited by this paper
• Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

  2001cited by this paper
• The ErbB receptor tyrosine family as signal integrators.

  2001cited by this paper
• Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

  2001cited by this paper
• The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.

  2000cited by this paper
• Role of HER2 gene overexpression in breast carcinoma

  2000cited by this paper
• Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation

  1999cited by this paper
• The prognosis of small primary breast cancers.

  1999cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Multiple imputation of missing blood pressure covariates in survival analysis.

  1999cited by this paper
• p21(WAF1) expression and endocrine response in breast cancer.

  1999cited by this paper
• p21WAF1 expression and endocrine response in breast cancer

  1999influential reference
• p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells

  1998cited by this paper
• Mechanisms and consequences of activation of protein kinase B/Akt.

  1998cited by this paper
• Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase.

  1998cited by this paper
• Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells

  1998cited by this paper
• Nuclear Accumulation of p21Cip1 at the Onset of Mitosis: a Role at the G2/M-Phase Transition

  1998cited by this paper
• Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells

  1998cited by this paper
• Increased level of p21 in human ovarian tumors is associated with increased expression of CDK2, cyclin A and PNCA

  1998cited by this paper
• WAF1/CIP1 protein expression in human breast tumors

  1997influential reference
• p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment.

  1996cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Radiation-induced cell cycle arrest compromised by p21 deficiency

  1995cited by this paper
• p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

  1995cited by this paper
• PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase

  1994cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Breast Cancer Research

  1978cited by this paper

• Design, synthesis and cytotoxic research of a novel antitumor model based on acrylamide–PABA analogs via β-tubulin inhibition

  2025cites this paper
• Cytoplasmic WEE1 promotes resistance to PD-1 blockade through hyperactivation of the HSP90A/TCL1/AKT signaling axis in NANOGhigh tumors.

  2025cites this paper
• p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients

  2024cites this paper
• BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21CIP1/WAF1

  2024cites this paper
• Cyclin-dependent kinase inhibitors in malignant hematopoiesis

  2022cites this paper
• Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death.

  2022cites this paper
• Cellular senescence in cancer: clinical detection and prognostic implications

  2022cites this paper
• The novel roles of virus infection-associated gene CDKN1A in chemoresistance and immune infiltration of glioblastoma

  2021cites this paper
• Ironing out the role of the cyclin‐dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity

  2019cites this paper
• The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy

  2019cites this paper
• Annurca apple polyphenol extract selectively kills MDA-MB-231 cells through ROS generation, sustained JNK activation and cell growth and survival inhibition

  2019cites this paper
• An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy

  2019cites this paper
• p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress

  2019cites this paper
• ITIH5 induces a shift in TGF‐β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death

  2018cites this paper
• Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2

  2018cites this paper
• The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect

  2018cites this paper
• Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.

  2018cites this paper
• p21Waf1/Cip1: its paradoxical effect in the regulation of breast cancer

  2018cites this paper
• The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer

  2017cites this paper
• Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin

  2017cites this paper
• Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by the chelator, Dp44mT.

  2017cites this paper
• Differential expression of cellular senescence markers in the assessment of breast cancer development

  2016cites this paper
• Mitochondrial regulation of cell cycle progression through SLC25A43.

  2016cites this paper
• Immunohistochemical expression of RUNX 3 and p 21 WAF 1 / CIP 1 and its correlation with clinicopathologic parameters in breast carcinoma of Egyptian women

  2016cites this paper
• CDK Inhibitors in Normal and Malignant Cells

  2016cites this paper
• Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.

  2015cites this paper
• Gene Expression Evaluation in Esophageal Cancer Patients

  2015cites this paper
• Expression of CDKN 1 A / p 21 and TGFBR 2 in breast cancer and their prognostic significance

  2015cites this paper
• Assessment of her2neu expression using immunohistochemistry in association with clinicopathological features and hormonal receptors in Iraqi breast cancer women patients

  2015cites this paper
• Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types

  2015cites this paper
• p21 Gene Expression Evaluation in Esophageal Cancer Patients

  2015cites this paper
• Original Article Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance

  2015cites this paper
• HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer

  2014cites this paper
• Immunohistochemical Expression of p21 in Ductal Carcinoma of the Breast and its Correlation with HER2/neu Expression and Hormonal Status

  2014cites this paper
• Less understood issues: p21Cip1 in mitosis and its therapeutic potential

  2014cites this paper
• Verrucarin A alters cell-cycle regulatory proteins and induces apoptosis through reactive oxygen species-dependent p38MAPK activation in the human breast cancer cell line MCF-7

  2014cites this paper
• Breast cancer status in India: An overview

  2013cites this paper
• Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.

  2013cites this paper
• TRIM3, a tumor suppressor linked to regulation of p21Waf1/Cip1

  2013cites this paper
• p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis

  2013cites this paper
• A novel p21 attenuator which is structurally related to sorafenib

  2013cites this paper
• Regulation of the cyclin-dependent kinase inhibitor p21 by TBX3

  2013cites this paper
• Characterisation of the novel melanoma associated Shc adaptor ShcD/RaLP

  2013cites this paper
• Pharmacodynamic study of the 7,8-dihydroxy-4-methylcoumarin-induced selective cytotoxicity toward U-937 leukemic cells versus mature monocytes: cytoplasmic p21(Cip1/WAF1) as resistance factor.

  2013cites this paper
• Analysis of Pathways Affected by the Viral Oncogenes in Human Papillomavirus 16-Induced Neoplastic Progression

  2013cites this paper
• The mitochondrial protein SLC25A43 and it's possible role in HER2-positive breast cancer

  2013cites this paper
• Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

  2012cites this paper
• Application of morphometry, static DNA ploidy analysis, and steroid receptor expression in diagnosis and prognosis of Libyan breast cancer

  2012cites this paper
• Expression and prognostic relevance of p21WAF1 in stage III esophageal squamous cell carcinoma.

  2012cites this paper
• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

  2012cites this paper
• The cyclin-dependent kinase inhibitor p21CDKN1A as a target of anti-cancer drugs.

  2012cites this paper
• Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression

  2012cites this paper
• A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion

  2012cites this paper
• FATS expression is associated with cisplatin sensitivity in non small cell lung cancer.

  2012cites this paper
• Cyclin-dependent kinase inhibitor p21Waf1: Contemporary view on its role in senescence and oncogenesis

  2012cites this paper
• Potential Roles of miR-106a in Breast Cancer

  2011cites this paper
• Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress.

  2011cites this paper
• EAPP modulates the activity of p21 and Chk2

  2011cites this paper
• Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

  2011cites this paper
• Profiling the HER3/PI3K Pathway in Breast Tumors Using Proximity-Directed Assays Identifies Correlations between Protein Complexes and Phosphoproteins

  2011cites this paper
• Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide

  2011cites this paper
• Therapeutics , Targets , and Chemical Biology CX-4945 , an Orally Bioavailable Selective Inhibitor of Protein Kinase CK 2 , Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

  2010cites this paper
• Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1).

  2010cites this paper
• An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis

  2010cites this paper
• Immunohistochemical expression of oestrogen and progesterone receptors during experimental acute and chronic murine Schistosomiasis mansoni.

  2010cites this paper
• CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.

  2010cites this paper
• Examination of the expanding pathways for the regulation of p21 expression and activity.

  2010cites this paper
• Downregulation of CDKN1A in Adult T-Cell Leukemia/Lymphoma despite Overexpression of CDKN1A in Human T-Lymphotropic Virus 1-Infected Cell Lines

  2010cites this paper
• Host cell factors in ovarian cancer influencing efficacy of oncolytic aenovirus dl922-947

  2010cites this paper
• A haploinsuficiência de Pkd1 aumenta a lesão renal e induz formação de microcistos após isquemia/reperfusão em camundongos

  2010cites this paper
• Applications of cellular systems biology in breast cancer patient stratification and diagnostics.

  2009cites this paper
• Tumor Suppressor Loss and Mitotic Checkpoint Overactivation as a Crossroads to Cancer

  2009cites this paper
• Her-2/neu, P-53, and Their Coexpression in Osteosarcoma

  2009cites this paper
• Role of apoptotic pathways in chemosensitivity of testicular germ cell tumour

  2009cites this paper
• Molecular mode of action and mechanism of resistance of the microtubule-stabilizing drug Sagopilone

  2009cites this paper
• p21 in cancer: intricate networks and multiple activities

  2009cites this paper
• High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers

  2008cites this paper
• Heregulin β 1 promotes breast cancer cell proliferation through Rac / ERK-dependent induction of cyclin D 1 and p 21 Cip 1

  2008cites this paper
• Tamoxifen-stimulated growth of breast cancer due to p21 loss

  2008cites this paper
• Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes

  2008cites this paper
• Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.

  2008cites this paper
• Expression of p 27 KIP 1 , p 21 WAF 1 and p 53 does Not Correlate with Prognosis in Node-negative Invasive Ductal Carcinoma of the Breast

  2008cites this paper
• A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.

  2008cites this paper
• Cell cycle machinery: links with genesis and treatment of breast cancer.

  2008cites this paper
• Expression of the HER family mRNA in breast cancer tissue and association with cell cycle inhibitors p21(waf1) and p27(kip1).

  2007cites this paper
• The Interplay Between KSHV-encoded Viral Cyclin and CDK-inhibitors p27Kip1 and p21Cip1 -implications for Viral Lymphomagenesis

  2007cites this paper
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007cites this paper
• p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches.

  2007cites this paper
• p 21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression : roscovitine augments p 21 levels

  2007cites this paper
• Interactions Between Myc- and Cyclin-DependentKinase Inhibitors in Cancer

  2007cites this paper
• Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas.

  2007cites this paper
• Author's response to reviews Title: p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: Roscovitine augments p21 levels Authors:

  2007cites this paper
• p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels

  2007cites this paper
• Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance

  2007cites this paper
• KLF4, p21 and context-dependent opposing forces in cancer

  2006cites this paper
• A new hypothesis on the role of c-erbB2 oncogene in the progress of breast cancer

  2006cites this paper
• Cytoplasmic p21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer.

  2006cites this paper
• The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study.

  2006cites this paper
• Cytoplasmic expression of p21CIP1/WAF1 is correlated with IKKbeta overexpression in human breast cancers.

  2006cites this paper
• Influence of nanomaterials on cell function

  2006cites this paper